216 related articles for article (PubMed ID: 11412101)
1. Mutational analysis of the K+-competitive inhibitor site of gastric H,K-ATPase.
Vagin O; Munson K; Lambrecht N; Karlish SJ; Sachs G
Biochemistry; 2001 Jun; 40(25):7480-90. PubMed ID: 11412101
[TBL] [Abstract][Full Text] [Related]
2. SCH28080, a K+-competitive inhibitor of the gastric H,K-ATPase, binds near the M5-6 luminal loop, preventing K+ access to the ion binding domain.
Vagin O; Denevich S; Munson K; Sachs G
Biochemistry; 2002 Oct; 41(42):12755-62. PubMed ID: 12379118
[TBL] [Abstract][Full Text] [Related]
3. Effects of mutations in M4 of the gastric H+,K+-ATPase on inhibition kinetics of SCH28080.
Munson KB; Lambrecht N; Sachs G
Biochemistry; 2000 Mar; 39(11):2997-3004. PubMed ID: 10715120
[TBL] [Abstract][Full Text] [Related]
4. Inhibitor and ion binding sites on the gastric H,K-ATPase.
Munson K; Garcia R; Sachs G
Biochemistry; 2005 Apr; 44(14):5267-84. PubMed ID: 15807521
[TBL] [Abstract][Full Text] [Related]
5. Inhibition kinetics of the gastric H,K-ATPase by K-competitive inhibitor SCH28080 as a tool for investigating the luminal ion pathway.
Vagin O; Munson K; Denevich S; Sachs G
Ann N Y Acad Sci; 2003 Apr; 986():111-5. PubMed ID: 12763783
[TBL] [Abstract][Full Text] [Related]
6. Comparison of covalent with reversible inhibitor binding sites of the gastric H,K-ATPase by site-directed mutagenesis.
Lambrecht N; Munson K; Vagin O; Sachs G
J Biol Chem; 2000 Feb; 275(6):4041-8. PubMed ID: 10660561
[TBL] [Abstract][Full Text] [Related]
7. The negative charge of glutamic acid-820 in the gastric H+,K+-ATPase alpha-subunit is essential for K+ activation of the enzyme activity.
Hermsen HP; Swarts HG; Koenderink JB; De Pont JJ
Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):465-72. PubMed ID: 9531486
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of putative SCH 28080 binding sites of the gastric H+,K+-ATPase.
Asano S; Matsuda S; Tega Y; Shimizu K; Sakamoto S; Takeguchi N
J Biol Chem; 1997 Jul; 272(28):17668-74. PubMed ID: 9211917
[TBL] [Abstract][Full Text] [Related]
9. Crystal structures of the gastric proton pump.
Abe K; Irie K; Nakanishi H; Suzuki H; Fujiyoshi Y
Nature; 2018 Apr; 556(7700):214-218. PubMed ID: 29618813
[TBL] [Abstract][Full Text] [Related]
10. Site-directed mutagenesis of cation coordinating residues in the gastric H,K-ATPase.
Rulli SJ; Louneva NM; Skripnikova EV; Rabon EC
Arch Biochem Biophys; 2001 Mar; 387(1):27-34. PubMed ID: 11368180
[TBL] [Abstract][Full Text] [Related]
11. Identification of the site of inhibition by omeprazole of a alpha-beta fusion protein of the H,K-ATPase using site-directed mutagenesis.
Lambrecht N; Corbett Z; Bayle D; Karlish SJ; Sachs G
J Biol Chem; 1998 May; 273(22):13719-28. PubMed ID: 9593713
[TBL] [Abstract][Full Text] [Related]
12. Designed inhibitors with hetero linkers for gastric proton pump H
Jana K; Bandyopadhyay T; Ganguly B
J Mol Graph Model; 2017 Nov; 78():129-138. PubMed ID: 29055186
[TBL] [Abstract][Full Text] [Related]
13. Functional expression of gastric H+,K(+)-ATPase and site-directed mutagenesis of the putative cation binding site and catalytic center.
Asano S; Tega Y; Konishi K; Fujioka M; Takeguchi N
J Biol Chem; 1996 Feb; 271(5):2740-5. PubMed ID: 8576249
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a novel potassium-competitive acid blocker of the gastric H,K-ATPase, 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate (TAK-438).
Shin JM; Inatomi N; Munson K; Strugatsky D; Tokhtaeva E; Vagin O; Sachs G
J Pharmacol Exp Ther; 2011 Nov; 339(2):412-20. PubMed ID: 21828261
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the gastric H,K ATPase for ion pathways and inhibitor binding sites.
Munson K; Law RJ; Sachs G
Biochemistry; 2007 May; 46(18):5398-417. PubMed ID: 17425287
[TBL] [Abstract][Full Text] [Related]
16. A chimeric gastric H+,K+-ATPase inhibitable with both ouabain and SCH 28080.
Asano S; Matsuda S; Hoshina S; Sakamoto S; Takeguchi N
J Biol Chem; 1999 Mar; 274(11):6848-54. PubMed ID: 10066737
[TBL] [Abstract][Full Text] [Related]
17. Cibenzoline, an ATP-sensitive K(+) channel blocker, binds to the K(+)-binding site from the cytoplasmic side of gastric H(+),K(+)-ATPase.
Tabuchi Y; Yashiro H; Hoshina S; Asano S; Takeguchi N
Br J Pharmacol; 2001 Dec; 134(8):1655-62. PubMed ID: 11739241
[TBL] [Abstract][Full Text] [Related]
18. Extracellular domains, transmembrane segments, and intracellular domains interact to determine the cation selectivity of Na,K- and gastric H,K-ATPase.
Mense M; Rajendran V; Blostein R; Caplan MJ
Biochemistry; 2002 Aug; 41(31):9803-12. PubMed ID: 12146946
[TBL] [Abstract][Full Text] [Related]
19. A hybrid between Na+,K+-ATPase and H+,K+-ATPase is sensitive to palytoxin, ouabain, and SCH 28080.
Farley RA; Schreiber S; Wang SG; Scheiner-Bobis G
J Biol Chem; 2001 Jan; 276(4):2608-15. PubMed ID: 11054424
[TBL] [Abstract][Full Text] [Related]
20. Molecular modeling of SCH28080 binding to the gastric H,K-ATPase and MgATP interactions with SERCA- and Na,K-ATPases.
Munson K; Vagin O; Sachs G; Karlish S
Ann N Y Acad Sci; 2003 Apr; 986():106-10. PubMed ID: 12763782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
